- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02463396
Mindfulness Training in Adults With ADHD
Mindfulness Training Versus Treatment as Usual in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Study Overview
Detailed Description
RATIONALE Attention Deficit Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder with a high persistence into adulthood. Patients with ADHD are primarily offered stimulant medication. However, not all patients are willing to take medication, some suffer from unacceptable side-effects and for many medication does not reduce their symptoms to the degree they would wish for. Therefore, there is a strong need for effective psychosocial interventions that are both accessible to a large group of patients and have been shown to be cost-effective, such as mindfulness training.
OBJECTIVE To examine the (cost)effectiveness of mindfulness versus treatment as usual (TAU) in adults with Attention Deficit Hyperactivity Disorder (ADHD).
HYPOTHESIS Mindfulness training will result in less ADHD symptoms, a better executive functioning, a better quality of life, and lower health care and societal costs.
STUDY DESIGN Randomised trial comparing mindfulness in addition to TAU with TAU alone. Baseline, end of treatment, follow-up 1 (6 months after baseline) and follow-up 2 (9 months after baseline) assessments will be done by blinded assessors and self-report questionnaires. After 9 months, patients allocated to the TAU condition will be offered mindfulness as well.
STUDY POPULATION N=120 adults with ADHD according to the DSM-5 using a structured psychiatric interview, referred to Radboudumc in Nijmegen, Reinier van Arkel in 's Hertogenbosch and Dimence in Deventer.
INTERVENTION The investigators have developed a treatment protocol of mindfulness for ADHD based on both the Mindfulness-Based Cognitive Therapy (MBCT) (Segal, Williams & Teasdale, 2013) and the mindfulness training for ADHD developed by Zylowska (2012).
STANDARD INTERVENTION TO BE COMPARED TO Treatment as usual, usually consisting of psychostimulants and psycho-education.
COST-EFFECTIVENESS ANALYSIS/ BUDGET IMPACT ANALYSIS Annual health care and societal cost savings are expected to be €1,2 million and €15,4 million, respectively.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6525 GC
- Radboudumc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
The investigators will include patients of 18 years and older who meet the following criteria:
- a primary diagnosis of ADHD, according to the criteria of Diagnostic and Statistical Manual of Mental Disorders - 4th edition (DSM-IV-TR) based on a structured Diagnostic Interview for ADHD, in adults (DIVA)
- capable of filling out questionnaires in Dutch
Exclusion Criteria:
- depressive disorder with psychotic symptoms or suicidality
- active manic episode
- borderline or antisocial personality disorder
- substance dependence
- autism spectrum disorder
- tic disorder with vocal tics
- learning difficulties or other cognitive impairments
- former participation in a MBCT or MBSR course
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Based Cognitive Therapy (MBCT) for ADHD
Adapted MBCT for ADHD
|
|
|
No Intervention: Treatment as usual (TAU)
Usually medication & psycho-education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in investigator-rated ADHD symptoms
Time Frame: baseline, 3, 6 and 9 months
|
Conners Adult ADHD Scale, investigator rating scale (CAARS-IR)
|
baseline, 3, 6 and 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in self-reported ADHD symptoms
Time Frame: baseline, 3, 6 and 9 months
|
Conners Adult ADHD Scale, self-report version (CAARS-S)
|
baseline, 3, 6 and 9 months
|
|
Change from baseline in executive functioning
Time Frame: baseline, 3, 6 and 9 months
|
Behavior Rating Inventory of Executive Function (BRIEF-A)
|
baseline, 3, 6 and 9 months
|
|
Change from baseline in patient functioning
Time Frame: baseline, 3, 6 and 9 months
|
Outcome Questionnaire 45.2 (OQ 45.2)
|
baseline, 3, 6 and 9 months
|
|
Change from baseline in mindfulness skills
Time Frame: baseline, 3, 6 and 9 months
|
Five Facet Mindfulness Questionnaire, short-form (FFMQ-SF)
|
baseline, 3, 6 and 9 months
|
|
Change from baseline in self-compassion
Time Frame: baseline, 3, 6 and 9 months
|
Self-Compassion Scale, short-form (SCS-SF)
|
baseline, 3, 6 and 9 months
|
|
Change from baseline in positive mental health
Time Frame: baseline, 3, 6 and 9 months
|
Mental Health Continuum, short-form (MHC-SF)
|
baseline, 3, 6 and 9 months
|
|
Change from baseline in health care consumption and productivity loss
Time Frame: baseline, 3, 6 and 9 months
|
Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness (TiC-P)
|
baseline, 3, 6 and 9 months
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Janssen L, Kan CC, Carpentier PJ, Sizoo B, Hepark S, Schellekens MPJ, Donders ART, Buitelaar JK, Speckens AEM. Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial. Psychol Med. 2019 Jan;49(1):55-65. doi: 10.1017/S0033291718000429. Epub 2018 Feb 28. Erratum In: Psychol Med. 2018 Aug;48(11):1920.
- Janssen L, Kan CC, Carpentier PJ, Sizoo B, Hepark S, Grutters J, Donders R, Buitelaar JK, Speckens AE. Mindfulness based cognitive therapy versus treatment as usual in adults with attention deficit hyperactivity disorder (ADHD). BMC Psychiatry. 2015 Sep 15;15:216. doi: 10.1186/s12888-015-0591-x.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NL48776.091.14
- 837001501 (Other Grant/Funding Number: ZonMw)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
St. Antonius HospitalNot yet recruitingADHD | Attention Deficit Disorder with Hyperactivity | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD, Predominantly Hyperactive - Impulsive | Attention Deficit Disorder (ADD) | Hyperactivity | Inattention | ADHD Predominantly Hyperactivity Type | ADHD-not Other Specified | Hyperactivity... and other conditions
-
Wuhan Sports UniversityTerminatedADHD | ADHD - Combined Type | ADHD - Inattentive Type | ADHD - Attention Deficit Disorder With Hyperactivity | ADHD Specifically With Executive Function ImpairmentChina
-
The Hong Kong Polytechnic UniversityRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Region Örebro CountyActive, not recruiting
-
University of TorontoCompleted
-
Massachusetts General HospitalCenter for Survey Research, University of Massachusetts, BostonCompleted
-
Akili Interactive Labs, Inc.Active, not recruiting
-
L'hôpital Nord-Ouest - Villefranche Villefranche...Completed
-
Johns Hopkins UniversityWithdrawn
Clinical Trials on MBCT for ADHD
-
Lakehead UniversityOntario Neurotrauma FoundationCompletedDepression | Traumatic Brain InjuryCanada
-
King's College LondonSouth London and Maudsley NHS Foundation TrustEnrolling by invitation
-
Dalhousie UniversityCompletedAttention Deficit Hyperactivity Disorder (ADHD)Canada
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Research Foundation FlandersCompleted
-
Massachusetts General HospitalCompletedDepression | Myocardial Infarction | Acute Coronary Syndrome | Unstable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MIUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedAttention Deficit Hyperactivity DisorderUnited States
-
University of IcelandActive, not recruitingAttention-deficit HyperactivityIceland
-
Oslo University HospitalLovisenberg Diakonale HospitalUnknownAttention Deficit Hyperactivity Disorder | Disruptive Mood Dysregulation DisorderNorway
-
Children's Hospital of PhiladelphiaCompletedAttention Deficit Hyperactivity DisorderUnited States